Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking

Division of Clinical Pharmacology and Experimental Therapeutics, San Francisco General Hospital Medical Center, California 94110.

OBJECTIVES. The purpose of this study was to examine the possible role of nicotine in enhancing coagulation and to assess the potential cardiovascular toxicity of transdermal nicotine therapy for smoking cessation. BACKGROUND. Cigarette smoking increases the risks of acute coronary events. A likely contributing mechanism is activation of coagulation. The role of nicotine in enhancing coagulability has not been resolved. METHODS. We compared in a crossover study the effects of cigarette smoking, transdermal nicotine and placebo transdermal nicotine, each for 5 days, in 12 healthy smokers. RESULTS. Cigarette smoking increased the urinary excretion of 11-dehydro-thromboxane B2 (reflecting thromboxane A2 generation) and increased plasma concentration of the platelet alpha-granule constituents, platelet factor 4 and beta-thromboglobulin, compared with placebo treatment, indicating in vivo platelet activation. Cigarette smoking was also associated with higher levels of fibrinogen in plasma. Transdermal nicotine produced plasma levels of nicotine in the same range as those during smoking but had no effect on thromboxane A2 metabolite excretion, platelet alpha-granule release or plasma fibrinogen, compared with placebo. Excretion of 2,3-dinor-6-keto-PGF1 alpha (reflecting prostacyclin generation) was not significantly influenced by any treatment. These results suggest that nicotine as such is not responsible for the platelet activation or elevation of plasma fibrinogen seen in smokers. However, we cannot exclude the possibility that intermittent bolus-like dosing of nicotine from cigarettes could have different effects from those produced by continually released transdermal nicotine. Other findings were that cigarette smoking and transdermal nicotine treatment were both associated with a higher white blood cell count compared with the placebo patch condition, suggesting a direct effect of nicotine to increase circulating white cells. Factor VII coagulant activity (VIIc) was significantly lower during cigarette smoking, than during either nicotine or placebo patch conditions. CONCLUSIONS. Transdermal nicotine has less effect on platelet activation and catecholamine release than does cigarette smoking, and its use in smoking cessation treatment of patients with coronary heart disease is likely to be safer than cigarette smoking.

This article has been cited by other articles:

				T. Raupach, K. Schafer, S. Konstantinides, and S. Andreas Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm Eur. Heart J., February 2, 2006; 27(4): 386 - 392. [Abstract] [Full Text] [PDF]

				C. L. Ford and J. A. Zlabek Nicotine Replacement Therapy and Cardiovascular Disease Mayo Clin. Proc., May 1, 2005; 80(5): 652 - 656. [Abstract] [PDF]

				V. F. Tapson The Role of Smoking in Coagulation and Thromboembolism in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2005; 2(1): 71 - 77. [Abstract] [Full Text] [PDF]

				S. Tsiara, M. Elisaf, and D. P. Mikhailidis Influence of Smoking on Predictors of Vascular Disease Angiology, September 1, 2003; 54(5): 507 - 530. [Abstract] [PDF]

				N. L. Kobrinsky, M. G. Klug, P. J. Hokanson, D. E. Sjolander, and L. Burd Impact of Smoking on Cancer Stage at Diagnosis J. Clin. Oncol., March 1, 2003; 21(5): 907 - 913. [Abstract] [Full Text] [PDF]

				N. L. Benowitz Basic cardiovascular research and its implications for the medicinal use of nicotine J. Am. Coll. Cardiol., February 5, 2003; 41(3): 497 - 498. [Full Text] [PDF]

				N. L. Benowitz, A. Hansson, and P. Jacob III Cardiovascular Effects of Nasal and Transdermal Nicotine and Cigarette Smoking Hypertension, June 1, 2002; 39(6): 1107 - 1112. [Abstract] [Full Text] [PDF]

				T. Neunteufl, S. Heher, K. Kostner, G. Mitulovic, S. Lehr, G. Khoschsorur, R. W. Schmid, G. Maurer, and T. Stefenelli Contribution of nicotine to acute endothelial dysfunction in long-term smokers J. Am. Coll. Cardiol., January 16, 2002; 39(2): 251 - 256. [Abstract] [Full Text] [PDF]

				S. Zevin, S. Saunders, S. G. Gourlay, P. Jacob III, and N. L. Benowitz Cardiovascular effects of carbon monoxide and cigarette smoking J. Am. Coll. Cardiol., November 15, 2001; 38(6): 1633 - 1638. [Abstract] [Full Text] [PDF]

				M.P. Pellegrini, D. E Newby, S. Maxwell, and D. J Webb Short-term effects of transdermal nicotine on acute tissue plasminogen activator release in vivo in man Cardiovasc Res, November 1, 2001; 52(2): 321 - 327. [Abstract] [Full Text] [PDF]

				S. E. Kimmel, J. A. Berlin, C. Miles, J. Jaskowiak, J. L. Carson, and B. L. Strom Risk of acute first myocardial infarction and use of nicotine patches in a general population J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1297 - 1302. [Abstract] [Full Text] [PDF]

				S. Matetzky, S. Tani, S. Kangavari, P. Dimayuga, J. Yano, H. Xu, K.-Y. Chyu, M. C. Fishbein, P. K. Shah, and B. Cercek Smoking Increases Tissue Factor Expression in Atherosclerotic Plaques : Implications for Plaque Thrombogenicity Circulation, August 8, 2000; 102(6): 602 - 604. [Abstract] [Full Text] [PDF]

				G. A O Thomas, J. Rhodes, J. T Green, and C. Richardson Role of smoking in inflammatory bowel disease: implications for therapy Postgrad. Med. J., May 1, 2000; 76(895): 273 - 279. [Abstract] [Full Text]

				K. Wilson, N. Gibson, A. Willan, and D. Cook Effect of Smoking Cessation on Mortality After Myocardial Infarction: Meta-analysis of Cohort Studies Arch Intern Med, April 10, 2000; 160(7): 939 - 944. [Abstract] [Full Text] [PDF]

				D Balfour, N Benowitz, K Fagerstrom, M Kunze, and U Keil Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report Eur. Heart J., March 2, 2000; 21(6): 438 - 445. [Abstract] [PDF]

				J. H. Markovitz, L. Tolbert, and S. E. Winders Increased Serotonin Receptor Density and Platelet GPIIb/IIIa Activation Among Smokers Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 762 - 766. [Abstract] [Full Text] [PDF]

				R. Zidovetzki, P. Chen, M. Fisher, F. M. Hofman, and F. M. Faraci Nicotine Increases Plasminogen Activator Inhibitor-1 Production by Human Brain Endothelial Cells via Protein Kinase C–Associated Pathway • Editorial Comment Stroke, March 1, 1999; 30(3): 651 - 655. [Abstract] [Full Text] [PDF]

				C. M. Mills, S. A. Hill, and R. Marks Transdermal Nicotine Suppresses Cutaneous Inflammation Arch Dermatol, July 1, 1997; 133(7): 823 - 825. [Abstract] [PDF]

				K. Fattinger, D. Verotta, and N. L. Benowitz J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1238 - 1246. [Abstract] [Full Text]

				I. Kawachi, G. A. Colditz, F. E. Speizer, J. E. Manson, M. J. Stampfer, W. C. Willett, and C. H. Hennekens A Prospective Study of Passive Smoking and Coronary Heart Disease Circulation, May 20, 1997; 95(10): 2374 - 2379. [Abstract] [Full Text]

				A. M. Joseph, S. M. Norman, L. H. Ferry, A. V. Prochazka, E. C. Westman, B. G. Steele, S. E. Sherman, M. Cleveland, D. O. Antonuccio, N. Hartman, et al. The Safety of Transdermal Nicotine as an Aid to Smoking Cessation in Patients with Cardiac Disease N. Engl. J. Med., December 12, 1996; 335(24): 1792 - 1798. [Abstract] [Full Text] [PDF]

				P. V. Petrik, H. A. Gelabert, W. S. Moore, W. Quinones-Baldrich, and M. M. Law Cigarette Smoking Accelerates Carotid Artery Intimal Hyperplasia in a Dose-Dependent Manner Stroke, August 1, 1995; 26(8): 1409 - 1414. [Abstract] [Full Text]

				N. L Benowitz Nicotine patches BMJ, May 27, 1995; 310(6991): 1409b - 1410. [Full Text]

				S. A. Glantz and W. W. Parmley Passive Smoking and Heart Disease: Mechanisms and Risk JAMA, April 5, 1995; 273(13): 1047 - 1053. [Abstract] [PDF]